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Abstract
Under the effects of climate change new drought tolerant crops are imperative to introduce in irrigated 
agricultural areas of Mediterranean countries. In this sense, hemp (Cannabis sativa L.) represents an alternative 
in many semi-arid agricultural areas of Mediterranean basin because of its low water requirements and cost 
effectiveness when it is developed under non controlled conditions. The aim of this work was to evaluate the 
potential yield of five new hemp varieties (Sara, Pilar, Aida, Theresa, and Juani) cultivated under high tunnel 
conditions in a semi-arid Mediterranean area, and also to study the effect of plant density on active biomass 
production and cannabinoids biosynthesis (cannabidiol, CBD and cannabigerol, CBG) at different plant 
positions. The trial was conducted under plastic macro-tunnels during two seasons (2014 and 2015), from May 
to October. The agronomic response and the chemical profiles of the studied varieties were evaluated at 
the end of each season. Moreover, it was monitored the differentiation in terms of active biomass production 
and cannabinoids biosynthesis in different plant organ positions (at upper, medium, and lower). Additionally, 
during the second season, three different plant densities (PD1, 9,777; PD2, 7,333; and PD3, 5,866 plants· ha-1) 
were tested in order to define the the best of them for maximizing CBD and CBG productions. The findings 
highlighted significant differences in yield between cultivars within the CBD and CBG. Moreover, plant density 
was a determinant factor related to active biomass production and cannabinoids contents, PD3 representing 
a suitable strategy to maximize the cannabinoids production minimizing the requirements of rooted apical 
cuttings. These results allowed concluding that these new hemp cultivars together with the adopted agronomic 
practices in this experience would be very appropriate for CBD and CBG productions, being determinant to 
consider the plant density and the cultivar for both studied chemotypes.
Keywords: cannabidiol, cannabigerol, Cannabis sativa L., plant density 
Introduction
Hemp (Cannabis sativa L.) is one of the most 
attractive multi-purpose crops because of the demand 
of non-food crops in agriculture and other derivatives 
as food sources (Carus et al., 2013; Andre et al., 2016). 
Traditionally, the most known uses and applications 
attributed to this crop were related to the textile industry, 
and in some cases, to obtain oil and seeds for animal 
feed or human food (Struik et al., 2000; Cappelletto et 
al., 2001; Bennet et al., 2006). However, one of the most 
promising hemp applications is related to the production 
of cannabinoids and other secondary metabolites 
(Maule, 2015; Cooper et al., 2018; Fiorini et al., 2019). In 
response to this situation, in recent times hemp cultivation 
for biomedical applications is increasing because 
of the booming demand for minor not psychotropic 
cannabinoids, particularly for cannabidiol (CBD) and 
cannabigerol (CBG) (Maxmen, 2018).
Within the most known cannabinoids, delta-
9-tetrahydrocannabínol (∆9-THC), CBD and CBG are 
the most important compounds (Cascio et al., 2010), 
although there are several other secondary metabolites, 
such as terpenoids and flavonoids, whose effects and 
interactions are being investigated (Potter, 2014; Lewis 
et al., 2018). ∆9-THC and CBD are biosynthesized from 
the same precursor, CBG. The ratio between ∆9-THC 
and CBD depend on the inheritance of two codominant 
genes (BT and BD) (Meijer et al., 2003). Thus, it can be 
found homozygous genotypes which have inherited 
the BT genes from each parent; and these genotypes 
will mainly produce ∆9-THC. On the contrary, other 
homozygous genotypes which have inherited the BD 
genes from each parent can be found and will mainly 
produce CBD. Nevertheless, large variations exist in the 
ratio between ∆9-THC and CBD in varieties characterized 
by ∆9-THC and CBD chemotypes. Another chemotype is 
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represented by those genotypes characterized by CBG 
as the dominant cannabinoid, obtained by the almost 
complete blockage of the metabolic pathways involved 
in the biosynthesis of CBD and ∆9-THC (Pacifico et al., 
2008). 
Biosynthesis and accumulation of cannabinoids is 
not exclusively governed by the plant genetic profile, but 
also by the growth conditions. In this regard, to obtain high 
concentrations of secondary metabolites together with a 
high yield on plant biomass, abundant light irradiation is 
required (Amaducci et al., 2008), and for this reason the 
hemp cultivation for biomedical applications in semi-arid 
Mediterranean areas seems to be promising. In this regard, 
recently, García-Tejero et al. (2019) developed a novelty 
experience in order to define the best agronomical 
practices (plant densities, irrigation dose, fertilization and 
sowing time) to maximize the cannabinoids production 
by using two monoecious industrial hemp cultivars (cv. 
Ermes, with a CBD-chemotype; and cv. Carma, with a 
CBG-chemotype). Moreover, these authors reported 
significant improvements when these plants were 
grown under polyethylene-covered tunnel structures, 
in comparison to the obtained results under open-field 
conditions. 
Within each chemotype, the most determinant 
factor to obtain a homogeneous chemical profile is 
related to the plant propagation material, this being 
very heterogeneous when plants are seed propagated 
(Huestis, 2007). Potter (2009) reported that it will be 
essential to achieve the maximum plant homogeneity for 
maximizing the yield, being the origin of plant propagation 
material a key factor to ensure plant homogeneity 
at harvest. In this context, the use of seeds would not 
be recommendable because a wide heterogeneity 
normally derives in progenies of traditional industrial 
hemp varieties; whereas the use of rooted apical cuttings 
would be the most advisable technique to obtain 
“clones” of a specific variety. Thus, asexually propagated 
new hemp varieties would be an efficient alternative for 
CBD and CBG production under open field conditions 
in comparison to traditional industrial hemp varieties. 
However, it is necessary to improve the knowledge about 
the effects of different agronomic practices, in terms of 
CBD and CBG synthesis, especially if hemp is going to be 
developed under non-controlled conditions.
Studies with experimental data related to field 
performance and potential yield of new hemp varieties 
for biomedical uses are scarce, and much less if these 
experiments are developed under field conditions, having 
a broad range of questions related to the hemp varieties 
adaptation and response, cannabinoids synthesis or 
agronomic practices to optimize the yields on specific 
cannabinoids.
Considering the previous experiences; the aim 
of this work was to evaluate the potential yield of five 
new hemp varieties (Sara, Pilar, Aida, Theresa, and Juani) 
cultivated under high tunnel conditions in a semi-arid 
Mediterranean area, and also to study the effect of plant 
density on active biomass production and cannabinoids 
biosynthesis (cannabidiol, CBD and cannabigerol, CBG) 
at different plant positions.
Material and Methods
Experimental site
The trial was carried out during two consecutive 
years (2014 and 2015) in an experimental farm belonging 
to the Andalusian Institute of Training and Agricultural 
Research (IFAPA, in Spanish); located in the Guadalquivir 
river basin, SW Spain (37º 301 47" N; 05º 581 0211 W) as 
the result of the established collaboration between IFAPA 
and Phytoplant Research S.L., this being one of the few 
Spanish companies authorized to carry out R&D on hemp 
for biomedical applications.
The local climate of the experimental area is 
typically Mediterranean-dry, with an annual reference 
evapotranspiration (ET0) of 1,200 mm and an annual 
rainfall of 550 mm, with a seasonal pattern, mainly 
distributed from October to April, which generates a 
potential deficit of -700 mm.
Regarding to the soil type, it is a Typical Fluvisol 
(USDA, 2016), with a useful depth up to 2.5 m, low content 
of organic matter (<15 g· kg-1), and available water 
holding capacity of 170 mm· m-1. More details about the 
experimental site characteristics can be found at García-
Tejero et al. (2019).
Plant material and field experimental conditions
Three new hemp varieties with CBD chemotype 
(Sara, Pilar, Theresa) and two with CBG chemotype (Aida 
and Juani) were tested. All of them were obtained by 
Phytoplant Research S.L. in indoor facilities by means 
of conventional plant breeding techniques, and then 
registered in the European Union Community Plant 
Variety Office. 
Plants were grown under polyethylene-covered 
tunnel structures (plastic macro-tunnels), whose 
dimensions were 50 x 6 m, with a maximum height of 3.5 m 
with inside average temperature between 23 and 35 ºC 
(with maximum temperatures > 40 ªC), relative humidity 
roughly 65%, and vapor pressure deficit (VPD) about 3.5 
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kPa (Figure 1A). The total surface for each high tunnel 
was 300 m2 but considering that it was necessary to keep 
a distance of 1 m from each side, and 3 m from each 
extreme, the useful surface was 176 m2.
Table 1 summarizes the experimental conditions 
and the properties for each hemp variety used during the 
two-monitoring seasons. 
During the studied seasons, irrigation doses were 
estimated according to the methodology proposed by 
Allen et al. (1998), and following the recommendations 
described by Cosentino et al. (2012).
For the first season (2014), three varieties were 
tested: Sara, Pilar, and Aida. Rooted cuttings were 
transplanted on 28 May; these ones were disposed 
Figure 1. Hemp cultivation inside of polyethylene-covered tunnel structures (plastic macro-tunnels) 
(A) and plant organ positions studied at harvest (B).
in ridges of 0.3 m of height, with 1 m between ridges, 
and 0.6 m between plants within each row; and a real 
plant density for each high-tunnel of 9,777 plants· ha-1. 
Previously to the transplanting operations, the soil was 
completely covered with a black plastic mesh, with the 
aim of controlling weeds. Irrigation and fertilization were 
independently managed. At the end of season, the total 
irrigation volume applied was close to 400 mm. Fertilization 
started on 13 June (16 days after transplanting), applying 
exclusively Terra Vega (CANNA España SL) fertilizer till 7 
July. After this, from 8 July to 31 July, two types of fertilizers 
(Terra Vega + Terra Flores, by CANNA España SL) were 
incorporated. Finally, from 31 July to seven days before 
harvesting, it was exclusively applied Terra Flores fertilizer. 
As Terra Vega as Terra Canna, both are liquid fertilizers 
for fertigation with a NPK composition of 3-1-1 and 2-2-
4, respectively. Both compositions contain other relevant 
micronutrients as Mg, B, S, Na, Cu, Fe, Mn, Mo and Zn in 
different composition and chelates as EDDHA, EDDTA, 
and DTPA to ensure the nutrient absorption by roots. At 
the end of the season, plants had received 115-75-160 
kg· ha-1 of NPK.
Throughout 2015, Pilar was suppressed and two 
Table 1. Experimental conditions and chemotype characteristic for hemp varieties used.
Hemp variety
2014 2015
PD TD HD PD TD HD
Sara  (CBD) PD1 28 May 29 Sept
PD1
PD2
PD3
27 May 21 Oct
Pilar (CBD) PD1 28 May 29 Sept --- ---
Aida (CBG) PD1 28 May 13 Oct
PD1
PD2
PD3
27 May 21 Oct
Theresa (CBD + CBDV) --- --- ---
PD1
PD2
PD3
27 May 14 Sept
Juani (CBG + CBGV) --- --- --- PD1 3 June 2 Oct
PD, plant density; PD1, PD2 and PD3 are 9,777, 7,333, and 5,866 plants ha-1, respectively; TD, transplanting date; HD, harvesting date; CBD, 
cannabidiol; CBG, cannabigerol; CBDV and CBGV are propyl variants of CBD and CBG, respectively.
were cultivated within the same high tunnels used in 
the previous season, and the rooted cuttings were 
new varieties (Theresa and Juani with CBD and CBG 
chemotypes, respectively), were tested. All varieties 
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transplanted at the end of May - beginning of June 
(Table 1). During this second season, and considering 
the scarce development of plant lateral growing in 2014, 
three different plant densities (PD) were tested: PD1, in 
which plants were disposed in rows 1 m spaced, and 0.6 
m between plants within each row; PD2, plants in rows 1 m 
spaced between them and 0.8 m between plants within 
each row; and PD3, with plants in rows 1 m spaced, and 
1 m between plants wthin each row. As it was pointed 
out before, according to the useful surface of the high-
tunnel structure, the real plant density for PD1, PD2 and PD3 
was 9,777, 7,333 and 5,866 plants· ha-1, respectively. In this 
regard, Sara, Aida and Theresa were grown under PD1, 
PD2 and PD3; whereas Juani, considering its morphology 
and reduced plant development (previously described 
by the company), was exclusively grown under PD1. As in 
the previous season, plants were grown above ridges of 
0.3 m of height and completely covering the soil with a 
black plastic mesh to control the weeds.
Related to the irrigation and fertilization 
scheduling, nutrients started to be applied one week 
after transplanting. As in the previous season, the 
first applications were done with Terra Vega, until 10 
August. From 11 August till harvesting was combined 
the application of Terra Vega with Terra Flores. At the 
end of the season, 100-50-150 kg· ha-1 of NPK was 
applied, these doses being equal for all varieties and PD. 
Regarding to the total irrigation water for each variety, it 
was 310 mm for Sara, Aida and Theresa, whereas Juani 
received 220 mm, this difference was related to height 
and the minor foliage development, but also to a shorter 
cultivation cycle. To ensure the harvesting date, stigma 
observations on weekly basis were done; stablishing 
the optimum maturity point by tracking the evolution of 
stigma’s color from white/yellow to orange/brown. Once 
approximately 80% of buds had reached this point; plants 
were harvested (this point differed depending on the 
variety and the growing conditions experimented during 
the seasons (Table 1). 
Plant measurements
At the end of the studied seasons, fresh weight 
(FW) of each plant was measured, using a precision 
balance (0.001 kg), and these were air dried in darkness 
for 7-10 days. Once the active biomass was dry enough 
(relative humidity below 12%), dry weight (DW) was 
recorded, leaves and flowers were pulled apart from the 
stems, obtaining dry weight of leaves and flowers [DW(F+L)], 
and the dry weight of stems and branches (DWstems) 
separately. Additionally, the active biomass content 
in plant organs distributed in three equal positions was 
measured: upper, medium, and lower (Figure 1B).
Cannabinoids contents [g per 100 g DW(F+L)] were 
measured by using the official method, (EC) No 1177/2000 
of 31 May 2000 Annex C, named “Community method 
for the quantitative determination of THC content of 
hemp varieties”. This method is based on the quantitative 
determination of Δ9-THC by gas chromatography 
although slight modifications were made in the 
temperature ramp of the chromatographic oven for the 
simultaneous determination of cannabinoids (CBDV, Δ9-
THCV, CBD, CBC, Δ8-THC, Δ9-THC, CBG, and CBN). 
More details about the proposed methodology 
to quantify the cannabinoids content can be found at 
García-Tejero et al. (2019). 
Experimental design and statistical analysis
In 2014, the experimental design was of 
randomized complete blocks, considering four 
replications per variety with an experimental plot unit of 4 
m x 6 m; with 4 rows per unit and 40 plants. Data obtained 
were subjected to a one-way variance analysis (ANOVA, 
SPSS 15 .0 statistical package; SPSS, Chicago, IL, USA), 
using a Tukey's test for mean separations (p < 0.05), and 
comparing all varieties. In this regard, the differences in 
terms of yield and biochemical compounds were studied, 
in order to define the best varieties for the production 
purposes. 
In 2015, the experimental design was similar to 
the previous season, in this case with two factors; the 
variety and the PD; considering four replications per 
variety and PD, respectively. Each experimental plot 
(replication) had a surface of 24 m2, with 40, 32, and 24 
plants, depending on the plant density (PD) considered. 
The studied parameters were subjected to a two-way 
ANOVA, studying the effects in terms of cultivar, PD, and 
the interactions between them. Previously, a Levene’s 
test was applied to verify the variances homogeneity. 
All statistical analysis was developed by using the 
SPSS 15.0 statistical package (SPSS, Chicago, IL, USA). 
Results
Biomass production of the studied varieties 
During 2014, Sara, Pilar and Aida varieties were 
transplanted on the same date and plant density with 
equal irrigation and fertilizer amounts. Related to the 
CBD varieties, Sara evidenced the most promising 
results in terms of fresh weight (FW), and total dry weight 
(DW), although referring to the active biomass (DW(F+L)), 
the differences with Pilar were not significant (Table 2). 
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Table 2. Yield parameters for studied hemp varieties during 2014.
Hemp variety FW DW
DW(F+L) UDW(F+L) MDW(F+L) LDW(F+L) DWStems Ratio
(kg· ha-1)
Sara (CBD) 25,938a 7,836a 3,478ab 290.2b 671.6ab 2,516a 4,358a 0.44b
Pilar (CBD) 17,069b 4,075b 2,769b 344.9ab 558.6b 1,865b 1,306b 0.68a
Aida (CBG) 32,414a 8,241a 4,190a 532.8a 904.9a 2,752a 4,051a 0.51ab
CBD, cannabidiol; CBG, cannabigerol; FW, fresh weight; DW, total dry weight; DW(F+L), dry weight of flowers and leaves; UDW(F+L), dry weight of flowers and leaves at upper position; 
MDW(F+L), dry weight of flowers and leaves at medium position; LDW(F+L), dry weight of flowers and leaves at lower position; Ratio, DWStems, dry weight of Stem and branches; DW(F+L) vs. 
DW. Different letters evidence significant differences among varieties at p < 0.05.
However, it was observed a significant improvement 
in terms of the ratio of active biomass; Pilar being a 
variety much smaller with a lower lateral development 
and producing much less stalks than Sara. In relation 
to the active biomass distribution, both Sara and Pilar 
accumulated the higher amounts of DW(F+L) in the lower 
third of the plant, although in percentage terms, Pilar had 
a higher amount of active biomass in the upper third of 
the plant than Sara (12.5 vs 8.3%), especially if we consider 
the total biomass produced for these cultivars. On the 
contrary, although Aida corresponded to a different 
chemotype, this variety was included within the statistical 
analysis with the remaining varieties, and no differences 
were found with Sara in terms of FW, DW, DW(F+L), being 
observed a similar pattern with the remaining cultivars, in 
terms of DW(F+L) distribution along the plant.
During 2015, two varieties with CBG chemotype 
(Aida and Juani) and two varieties with CBD chemotype 
(Sara and Theresa) were tested, and all of them (except 
for Juani) were grown at three different plant densities, 
analyzing the differences in terms of variety, plant density, 
and the interaction between these parameters.
In the case of CBD chemotype, significant 
differences in yield were found between cultivars and 
between the different PD considered. In this agreement, 
in terms of cultivar, these effects were observed in the FW, 
DW, LDW(F+L), DWStems and the ratio of active biomass (Table 
3). It is noticeable that Theresa registered a significant 
improvement in terms of the ratio of active biomass (0.62), 
although on overall, Sara was much more productive 
than Theresa, obtaining almost 83% more active biomass. 
Relating to the PD effects, both PD1 and PD3 showed the 
best results, especially for the different parameters of DW 
studied in this work (Table 3). When there were studied 
the effects of PD within each cultivar; the most relevant 
findings were fixed for Sara PD1, followed by Sara PD3 
and Theresa PD1 and PD3, focusing the differences in 
these cases in terms of the ratio of active biomass (Table 
3). Finally, as it was observed in the previous season the 
highest amounts of active biomass were produced in the 
lower plant section, this fact being observed in both CBD 
cultivars.
In the case of CBG chemotype, regarding to 
the variety effect, significant effects were observed 
exclusively for MDW(F+L), DWStems and the ratio between 
DW vs. DW(F+L). In this sense, Juani evidenced a significant 
improvement in terms of active biomass production 
regarding to total dry weight in the medium position 
of the plant (Table 4), this fact being related with the 
specific plant morphology and development of Juani, 
which was able to produce on overall better results 
of active biomass than Aida. Moreover, although no 
significant differences between cultivars were observed 
in terms of DW, Juani offered improvements in terms of 
the ratio of active biomass in comparison to Aida, when 
both varieties were grown under the same PD. In this 
agreement, regarding to the effects promoted by PD, this 
was exclusively studied for Aida, because Juani was only 
grown under PD1. Nevertheless, no effects were detected 
in terms of PD for Aida (Tables 3 and 4), being these results 
different from those obtained for the CBD varieties.
Cannabinoids production of the studied varieties
During 2014, the main composition in terms 
of cannabinoids in the three varieties was studied by 
selecting different sections of the plant position (upper, 
medium or lower). Significant differences in the chemical 
profile were observed among varieties, these contents 
not being affected by the plant position (Table 5). 
Pertaining to the variety, Sara was the most 
effective in terms of CBD and CBDV cannabinoids, even for 
the remaining cannabinoids analyzed; except for the case 
of CBG, in agreement with the chemotype represented 
for this variety (Table 5). In this line, the total amount of 
cannabinoids synthetized by this variety was 77% higher 
than for the case of Pilar and Aida, this being an important 
characteristic of this variety (Table 5). These results would 
reinforce those previously discussed related to the active 
biomass production, being Sara the best variety as it has 
been previously described. On the other hand, in relation 
to the distribution of cannabinoids biosynthesis in different 
plant organs position, it was noted a certain trend to 
produce higher contents in the upper and medium parts, 
in accordance to the maximum concentration of flowers 
in these parts. This fact was detected for CBG (Aida being 
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Table 4. Impact of hemp variety and plant density on yield parameters for CBG chemotype during 2015. 
Yield 
parameters
Variety All cases
Aida Juani Aida PD1 Aida PD2 Aida PD3 Juani PD1
(kg· ha-1)
FW 18,752a 23,318a 21,085a 15,605a 19,567a 23,318a
DW 6,501a 7,249a 7,598a 5,353a 6,553a 7,249a
DW(F+L) 2,965a 4,777a 3,284a 2,588a 3,024a 4,777a
UDW(F+L) 359.9a 460.7a 446.3a 365a 268.5a 460.7a
MDW(F+L) 695.5b 1,664a 866.1ab 480.9b 739.5ab 1,664a
LDW(F+L) 1,910a 2,652a 1,972a 1,742a 216.4a 2,652a
DWStems 3,464a 2,370b 4,225a 2,693ab 3,475ab 2,370b
Ratio 0.46b 0.66a 0.43b 0.49b 0.46b 0.66a
FW, fresh weight; DW, total dry weight; DW(F+L), dry weight of flowers and leaves; UDW(F+L), dry weight of flowers and leaves at upper position; MDW(F+L), dry weight of flowers 
and leaves at medium position; LDW(F+L), dry weight of flowers and leaves at lower position; DWStems, dry weight of Stem and branches; Ratio, DW(F+L) vs. DW; PD1, PD2 and 
PD3 are 9,777, 7,333, and 5,866 plants per hectare. Different letters evidence significant differences among varieties at p < 0.05.
the only variety corresponding to this chemotype) and 
total cannabinoids, with significant differences among 
Table 5. Impact of hemp variety and plant organ positions on cannabinoids content during 2014.
Cannabinoids
Varieties Plant organ positions
Sara Pilar Aida Upper Medium Lower
(g per 100 g DM)
CBDV 0.114a 0.041b 0.020c 0.040a 0.039a 0.039a
CBCV 0.024a 0.008b 0.007b 0.009a 0.009a 0.009a
CBD 8.090a 4.781b 1.051c 3.538a 3.511a 3.473a
CBC 0.370a 0.194b 0.120b 0.183a 0.178a 0.167a
∆9-THC 0.547a 0.303b 0.065c 0.232a 0.223a 0.216a
CBG 0.499b 0.170b 4.484a 2.264a 2.105a 1.383b
CBN 0.201a 0.073b 0.002c 0.057a 0.055a 0.048a
Total 9.900a 5.600b 5.600b 6.349a 6.144a 5.356b
CBD, cannabidiol; CBG, cannabigerol; CBC, cannabichromene; ∆9-THC, Delta-9-tetrahydrocannabinol; CBN, cannabinol. CBDV and CBCV are propyl variants of CBD 
and CBC, respectively. Different letters evidence significant differences among varieties at p < 0.05
Table 3. Impact of hemp variety and plant density on yield parameters for CBD chemotype during 2015.
Yield 
parameters
Variety Plant Density Variety x Plant Density
Sara Theresa PD1 PD2 PD3
Sara
PD1
Sara
PD2
Sara
PD3
Theresa 
PD1
Theresa 
PD2
Theresa 
PD3
(kg· ha-1)
FW 17,408a 12,332b 18,835a 12,570b 13,204ab 23,806a 12,392b 16,026ab 13,864b 12,748b 10,382b
DW 6,214a 3,390b 6,330a 3,613b 4,462a 8,494a 4,368bc 5,781b 4,167bc 2,859c 3,144c
DW(F+L) 2,369a 2,067a 2,901a 1,636b 2,117ab 3,307a 1,631b 2,170ab 2,495ab 1,641b 2,064ab
UDW(F+L) 354.5a 284.6a 388.8a 207.6b 362.1a 425.1a 196.9b 441.5a 352.7ab 218.3b 282.7ab
MDW(F+L) 873.1a 859.9a 890.1ab 598.3b 1,111a 582.2bc 488.7c 1,548a 1,198ab 707.9c 673.7bc
LDW(F+L) 1,863a 922.5b 1,622a 917.8b 1,639a 2,299a 1,120b 2,170a 944.8b 714.7b 1,107b
DWStems 3,776a 1,318b 3,385a 1,912b 2,345a 5,099a 2,673bc 3,556ab 1,671c 1,151c 1,134c
Ratio 0.40b 0.62a 0.50a 0.51a 0.52a 0.38c 0.43bc 0.39c 0.62a 0.59ab 0.65a
FW, fresh weight; DW, total dry weight; DW(F+L), dry weight of flowers and leaves; UDW(F+L), dry weight of flowers and leaves at upper position; MDW(F+L), dry weight of flowers and leaves at 
medium position; LDW(F+L), dry weight of flowers and leaves at lower position; DWStems, dry weight of Stem and branches; Ratio, DW(F+L) vs. DW; PD1, PD2 and PD3 are 9,778, 7,333, and 5,866 plants 
per hectare. Different letters evidence significant differences among varieties at p < 0.05.
the upper and medium positions with respect to the lower 
position.
In the second experimental year (2015), three 
different densities (9,777; 7,333, and 5,866 plants· ha-1) 
were studied for Sara, Theresa, and Aida; whereas for 
the case of Juani, this variety was grown exclusively at 
9,777 plants· ha-1. Additionally, as it was done during the 
previous season, it was considered the differentiation of 
cannabinoids biosynthesis taking into account the plant 
aerial position (upper, medium and lower). 
Assuming the effects of the variety, the results 
showed significant differences in all the cannabinoids 
analyzed, something similar to the observations in the 
previous season (Table 6). In this sense, Sara and Theresa 
produced higher amounts of CBD, in comparison to 
Juani and Aida, which were the varieties that produced 
higher amounts of CBG as shown in Table 6. Among 
those cultivars belonging to the same chemotype, some 
interesting differences between Sara and Theresa were 
observed. Thus, Theresa reached higher values of CBDV, 
whereas Sara reached higher levels of CBC and CBN. 
Something similar was observed in the CBG-varieties. 
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Thus, Aida produced the highest content of CBG and 
total cannabinoids on overall, highlighting the levels of 
CBC, in comparison to Juani. 
More relevant were the results related to the 
effects of PD in the cannabinoids production. In this sense, 
significant effects were observed in all of them except of 
CBG, something interesting to be considered in order to 
achieve equilibrium between cannabinoids and plants 
production. In this regard, it is remarkable that PD3 was the 
most productive density in terms of total cannabinoids, 
followed by PD2 and PD1 (Table 6). Moreover, between 
the most affected cannabinoids because of the PD were 
CBD, ∆9-THC or CBC. A significant effect derived from the 
plant organs position was found. On overall, upper and 
medium positions were the most productive, with slight 
variations depending on the considered cannabinoid 
(Table 6). It is noticeable the improvements obtained for 
CBDV, ∆9-THCV, CBD, CBC or CBN. By the contrary, only 
CBG was the cannabinoid that reached the highest 
contents in the lower position. 
In order to normalize the obtained results in 
terms of total cannabinoids production (kg·ha-1) these 
were calculated taking into account the active biomass 
(DW(F+L)) obtained under the different growing conditions 
and the ratio of cannabinoids (g cannabinoid per 100 
g DM(F+L)) in the different cultivars, PD and plant organs 
positions (g cannabinoid per 100 g DM(F+L)). According 
to our findings, the highest productions of CBD were 
obtained in Sara under PD1 and PD3, and the worst 
in Theresa (Table 7). Related to the CBG varieties, no 
substantial differences were found between Aida and 
Juani, although the highest CBG productions in these 
cultivars and under PD1 were obtained by Juani (Table 7). 
Table 6. Impact of variety, plant density, and plant organ positions on cannabinoid contents during 2015.
Cannabinoids
Variety Plant Density Plant organ position
Sara Aida Theresa Juani PD1 PD2 PD3 Upper Medium Lower
(g cannabinoid per100 g DM(F+L))
CBDV 0.24b 0.13c 1.55a 0.15c 0.63b 0.89a 0.65b 0.77a 0.71a 0.62c
∆9-THCV 0.05b 0.01c 0.21a 0.01c 0.08c 0.13a 0.10b 0.10a 0.10a 0.08c
CBD 10.1a 0.85c 4.17b 0.36d 3.64b 3.67b 4.96a 4.05a 3.97a 3.72b
CBC 0.55a 0.22c 0.30b 0.19d 0.30b 0.30b 0.36a 0.37a 0.29b 0.28b
∆9-THC 0.92a 0.11c 0.53b 0.05d 0.38c 0.45b 0.53a 0.41b 0.45a 0.42ab
CBG 0.78c 4.84a 0.45c 3.98b 2.29a 2.15a 2.00a 1.65b 2.49a 2.41a
CBN 0.12a 0.04b 0.05b 0.02c 0.05b 0.06b 0.07a 0.10a 0.04b 0.03b
Total 12.8a 6.20c 7.29b 4.78d 7.38b 7.52b 8.83a 7.53b 8.05a 7.55b
CBD, cannabidiol; CBG, cannabigerol; CBC, cannabichromene; ∆9-THC, Delta9-tetrahydrocannabinol; CBN, cannabinol. CBDV and ∆9-THCV correspond to the propyl variants of CBD and ∆9-THC, 
respectively; PD1, PD2 and PD3 are 9,777, 7,333, and 5,866 plants per hectare. Different letters evidence significant differences among varieties at p < 0.05.
Table 7. Average cannabidiol, cannabigerol and total cannabinoids production for the studied varieties under different plant 
densities during the two-monitoring seasons.
Hemp 
variety
CBD contents CBG contents Total cannabinoids
2014 2015 2014 2015 2014 2015
PD1 PD1 PD2 PD3 PD1 PD1 PD2 PD3 PD1 PD1 PD2 PD3
(kg· ha-1)
Sara 281.5a 354.5a 155a 206.7a 17.4b 26.5c 12.4b 16.7b 344.4a 448.8a 197.4a 218.6a
Pilar 132.4b 4.7c 155.1c
Theresa 104.8b 66.0b 91.5b 11.0bc 7.22b 10.1b 180.2b 115.7b 165.6b
Aida 44.0c 27.3c 22.8c 25.4c 187.9a 144.9b 134.6a 150a 234.6b 188.9b 171.4a 190.5a
Juani 17.2c 190.2a 228.4b
CBD, cannabidiol; CBG, cannabigerol; Total, total cannabinoids (whole cannabinoids studied in this work). PD1, PD2, and PD3 are 9,777, 7,333, and 5,866 plants per hectare. Different letters differ 
significantly for each cannabinoid, and between the cases of a same chemotype (Sara, Pilar, and Theresa are CBD chemotype; Aida and Juani are CBG chemotype). Different letters within each 
column evidence significant differences among varieties at p < 0.05.
Discussion
This work examines two novelties approaches 
for cannabis production for biomedical purposes: i) the 
usage of new hemp varieties with a negligible synthesis of 
psychotropic cannabinoids, and higher concentrations 
of other therapeutic cannabinoids (mainly CBD and 
CBG); ii) and stablishing the most suitable PD in order to 
maximize the cannabinoids production.
The first experience focused on studying the 
cultivation of traditional industrial hemp varieties for 
biomedical applications under non-controlled conditions 
were recently developed by García-Tejero et al. (2019). 
These authors concluded that several improvements in 
terms of final yield could be obtained when this crop was 
grown under high tunnels, in comparison to open-field 
conditions. 
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In relation to active biomass production, 
comparing our findings with those reported when fibre 
varieties were used, and using the similar PD, irrigation 
doses, sowing time and cropping system, García-Tejero 
et al. (2019) reported DW(F+L) values close to 2,400 kg· ha-1 
for Ermes (CBD Chemotype), whereas, for the new CBD 
varieties tested in this work, the results oscillated between 
3,478 and 3,307 kg· ha-1 in case of Sara (Tables 2 and 3); 
2,495 and 1,641 kg· ha-1 for Theresa (Table 3); and 2,769 
kg· ha-1 for Pilar (Table 2). According to this, on overall, 
a significant improvement in DW(F+L) production was 
reached with in the varieties tested in this experience.  
In addition, considering the CBG varieties, 
and the previous results provided by García-Tejero et 
al. (2019), these authors reported maximum values of 
DW(F+L) for Carma variety around 4,550 kg· ha-1. These 
results were slightly higher than those harvested for Aida, 
with maximum productions of 4,190 kg· ha-1 in 2014 and 
between 3,284 to 3,024 kg· ha-1 in 2015, depending on 
the PD (Tables 2 and 4). For the case of Juani, (the other 
CBG variety tested in this work) the DW(F+L) values were 
close to 4,800 kg· ha-1 (Table 4), even higher than those 
reported for Carma by García-Tejero et al. (2019).
 In order to define the most appropriate cultivar 
and plant PD to maximize the total cannabinoids 
production (cannabinoids harvesting; kg·ha-1), it will be 
determined by two factors: i) the total active biomass 
produced (DWF+L); ii) and the plant capability to synthesize 
cannabinoids in its tissues (very high in flowers and leaves, 
low or very low in stems and branches; and almost non-
existent in seeds and roots), (Khan et al. 2014; Andre et 
al. 2016). 
Focusing the attention in the total active biomass, 
on overall, PD1 and PD3 reported the best results in terms 
of DWF+L. This controversy would be explained according 
to these reasonings: the number of plants per hectare 
and the plant capability for an optimum lateral spread. 
In this sense, PD1 relied on the highest number of plants 
per hectare; and thus, the potential production would 
be very relevant. However, taking into consideration that 
the distance between plants in the same row for PD1 (0.6 
m) was the lowest; the lateral development is limited, 
unlike PD3, with the lowest number of plants but the 
highest distance between plants in the same row, and 
hence the highest lateral development. These conditions 
would explain the similar results in terms of DWF+L for PD1 
and PD3, as it was observed for the case of Aida (Table 4) 
with a lateral development more pronounced than the 
observed in Juani. Likewise, and focusing exclusively the 
improvements in terms of active biomass production, no 
significant differences were observed between Aida and 
Juani for PD1. Relating to the CBD cultivars, the best results 
were obtained for Sara cultivar under PD1 and PD3, much 
higher than the productions values of DW(F+L) obtained 
in Pilar (Table 2) and Theresa (Table 3) in 2014 and 2015, 
respectively. These differences are specially related with 
the plant morphology and size. In accordance to this, Sara 
highlights for a very relevant volume and a lateral growing 
very pronounced. Although its inflorescences are not very 
compact, this variety counts on with a high capability of 
developing them, and hence, it is considered as one of 
the most relevant CBD chemotype currently obtained by 
the company Phytoplant Research S.L. 
In relation to the ratio of cannabinoids, in 2014 
(Table 5) Sara reported higher CBD concentrations 
than Pilar and other related cannabinoids, whereas in 
2015 (Table 6) this variety was again the most relevant 
within the CBD chemotype. These results would reinforce 
the advantage of Sara as a promising CBD variety, 
comparing to other cultivars that at present, are being 
studied. For the case of CBG chemotype, in 2014 Aida 
reported a ratio of CBG of 4.48 g·100 g-1 DWF+L (Table 5), 
whereas in 2015 (Table 6) this same cultivar .reported 
similar concentrations of CBG (4.84 g 100-1 DWF+L) L; in 
comparison to Juani, with CBG values around 3.98 g·100 
g-1 DWF+L.
Linking the active biomass production and the 
synthesis of cannabinoids (Table 7), the cultivar would be 
the most determinant factor within the CBD chemotype, 
Sara reporting the best results, whereas for the case of 
CBG chemotype, Juani would be the most relevant. 
Comparing these results with those reported 
by García-Tejero et al. (2019) when studying the 
cannabinoids production by using varieties for industrial 
uses; it was fixed in the best of the cases (under high-
tunnels) a total amount of CBD close to 48.67 kg· ha-1 for 
Ermes (14% of total CBD produced by Sara under PD1 in 
2015). 
Moreover, considering the CBG amount recorded 
for Carma (118.0 kg· ha-1) in the best of the studied cases, 
this represents 62% of the total CBG produced by Juani 
under PD1. 
According to Barrat et al. (2012), in recent years, 
this crop is witnessing a revival and many researchers have 
studied the potential usage and applications of different 
non psychotropic cannabinoids (such as CBD and 
CBG) for biomedical purposes because of its interaction 
capability to contribute to the pharmacological power 
of medicinal hemp extracts (Russo & Taming, 2011). One 
example of these new applications was the approval 
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of Sativex in June 2011 for treating spasticity caused 
by multiple sclerosis, or the development of different 
experiments for synthetic production of ∆9-THC and 
cannabidiolic acid by means of genetically modified 
microorganisms (Zirpel et al., 2015).
Conversely, several authors have reported 
the significant improvements in terms of cannabinoids 
concentration in different plant tissues when comparing 
fiber versus drug cultivars. In this agreement, THC 
concentrations were between 4 to 30 times higher in 
leaves of drug cultivars than fiber type cultivars (Potter, 
2004; Pacifico et al., 2008; Bruci et al., 2012). Something 
similar was found in case of CBD and CBG concentrations 
in flowers and leaves, these levels are among 2 and 20 
times higher in drug-type cultivars than in fiber-types 
(Cappelletto et al., 2001; Stout et al., 2012).
In particular, the CBD content was higher than 
those reported by Janatová et al. (2018) when they used 
similar cultivars belonging to this same chemotype. These 
authors obtained between 0.49 and 0.60 g CBD per 100 
g of dry matter, developing six production cycles under 
indoor conditions. Therefore, according to the findings of 
the present study, the CBD productions were up to 350 
kg· ha-1, whereas, under indoor controlled conditions, 
Janatová et al. (2018) would be able of producing, and 
taking into account their best results, around 84 kg· ha-1 
CBD, with the difference that these authors developed 
six production cycles during a year and under indoor 
facilities, with high energy costs. Thus, the use of these 
new varieties under the growing conditions defined in 
previous experiments would ensure a high cost-effective 
production of non-psychotropic cannabinoids with 
significant energy savings and positioning the hemp as 
a good alternative to other irrigated crops in semi-arid 
Mediterranean areas such as South Spain.
Conclusions
This work presents novelty findings in terms of 
active biomass and cannabinoids production when 
using new hemp varieties for biomedical purposes, 
obtained from traditional plant breeding techniques. 
Plant density was identified as a determinant factor to 
maximize production, being PD1 (9,777plants ha-1) the 
most advisable in terms of total yield of cannabinoids, 
although higher costs must be considered for the nursery 
stage. However, some improvements were recorded for 
PD3 (5,866 plants ha-1), especially because of the higher 
plants’ capability for a lateral development. 
Regarding the studied varieties, Sara resulted the 
CBD variety with the highest yield, followed by Pilar and 
Theresa, whereas with the CBG varieties no significant 
differences were found among them. Nevertheless, it is 
worth to develop and breed new hemp varieties with 
biomedical applications in order to increase the final 
production of its main cannabinoid under Mediterranean 
semiarid environment. 
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